Australia's Starpharma rises on Vietnam export deal for COVID-19 nasal spray

Starpharma Holdings

26/10/2021 02:24

** Drug developer Starpharma Holdings  SPL.AX  climbs as
much as 3.7% to A$1.12, marking its best day since Oct. 8
    ** Co confirms its Viraleze coronavirus nasal spray would be
exported to Vietnam  urn:newsml:reuters.com:*:nASX60J6Tw
    ** SPL has inked a deal with Truong Bao Land, which will
import and distribute the product
    ** Says first delivery of product into Vietnam is expected
in early November
    ** The product, which is designed as a preventative measure
alongside vaccines, has not yet been approved for use in
Australia
    ** Stock down about 31% YTD, as of last close vs a 13.2%
increase in the ASX All Ordinaries index  .AORD  
    


 (Reporting by Riya Sharma in Bengaluru)
 ((Riya.Sharma@thomsonreuters.com;))